Impact of SARS-CoV-2 omicron BA.1 and delta AY.4.2 variants on the neutralization by sera of patients treated with different authorized monoclonal antibodies / F. Dragoni, E. Schiaroli, V. Micheli, L. Fiaschi, A. Lai, G. Zehender, B. Rossetti, M.R. Gismondo, D. Francisci, M. Zazzi, I. Vicenti. - In: CLINICAL MICROBIOLOGY AND INFECTION. - ISSN 1469-0691. - 28:7(2022), pp. 1037-1039. [10.1016/j.cmi.2022.03.005]
Impact of SARS-CoV-2 omicron BA.1 and delta AY.4.2 variants on the neutralization by sera of patients treated with different authorized monoclonal antibodies
V. Micheli;A. Lai;G. Zehender;M.R. Gismondo;
2022
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Dragoni, ClinMicrInf 22, SARS-CoV-2 veriant neutralization.pdf
accesso aperto
Tipologia:
Publisher's version/PDF
Dimensione
567.65 kB
Formato
Adobe PDF
|
567.65 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
